BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15150277)

  • 21. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
    Tang L; Han X
    Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
    Xing RH; Mazar A; Henkin J; Rabbani SA
    Cancer Res; 1997 Aug; 57(16):3585-93. PubMed ID: 9270032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells.
    Velpula KK; Gogineni VR; Nalla AK; Dinh DH; Rao JS
    Neoplasia; 2013 Feb; 15(2):192-203. PubMed ID: 23441133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
    Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
    Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
    Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
    Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies.
    Rabbani SA; Xing RH
    Int J Oncol; 1998 Apr; 12(4):911-20. PubMed ID: 9499455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.
    Dunn SE; Torres JV; Nihei N; Barrett JC
    Mol Carcinog; 2000 Jan; 27(1):10-7. PubMed ID: 10642432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.
    Bagheri-Yarmand R; Mazumdar A; Sahin AA; Kumar R
    Int J Cancer; 2006 Jun; 118(11):2703-10. PubMed ID: 16381000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
    Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
    Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor.
    Watabe T; Yoshida K; Shindoh M; Kaya M; Fujikawa K; Sato H; Seiki M; Ishii S; Fujinaga K
    Int J Cancer; 1998 Jul; 77(1):128-37. PubMed ID: 9639404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells.
    Slivova V; Zaloga G; DeMichele SJ; Mukerji P; Huang YS; Siddiqui R; Harvey K; Valachovicova T; Sliva D
    Nutr Cancer; 2005; 52(1):66-73. PubMed ID: 16091006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.
    Belaguli NS; Aftab M; Rigi M; Zhang M; Albo D; Berger DH
    Neoplasia; 2010 Nov; 12(11):856-65. PubMed ID: 21076612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine.
    Detich N; Hamm S; Just G; Knox JD; Szyf M
    J Biol Chem; 2003 Jun; 278(23):20812-20. PubMed ID: 12676953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
    Sliva D; English D; Lyons D; Lloyd FP
    Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.